The global softgel capsules market is projected to reach USD 2,339.5 million by 2036, increasing from USD 1,245.3 million in 2025, according to Future Market Insights (FMI). The market is estimated at USD 1,318.8 million in 2026 and is forecast to expand at a compound annual growth rate (CAGR) of 5.9% between 2026 and 2036.

Growing consumption of vitamin and dietary supplements, increasing demand for oil-based formulations, rising adoption of liquid-filled pharmaceutical products and expanding contract manufacturing capabilities are supporting market expansion. Advances in plant-based capsule shells and increasing demand for vegetarian supplement formats are also creating opportunities for manufacturers. South Korea, India and the United States are among the countries presenting attractive growth prospects.

Request For a Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-15724

The Short Version

· Market expansion: The softgel capsules market is forecast to increase from USD 1,318.8 million in 2026 to USD 2,339.5 million by 2036, registering a 5.9% CAGR.

· Product leadership: Gelatin softgel capsules account for 73.1% of product sales in 2026, while vegetarian softgels represent 26.9%.

· Raw material leadership: Type-A gelatin from pork skin accounts for 42.0% of raw material demand.

· Application leadership: Vitamin and dietary supplements represent 31.4% of application demand in 2026.

· Geographical opportunities: South Korea records the highest country-wise CAGR at 6.1%, followed by India and the United States at 6.0% each.

Three Numbers That Matter

USD 2.34 billion: The projected global market value by 2036, reflecting growing demand for convenient oral dosage forms across pharmaceutical and nutritional supplement applications.

73.1%: The estimated share of gelatin softgel capsules within the product category in 2026. Their established manufacturing processes, elastic shell structure and suitability for liquid and oil-based fills support their leading position.

31.4%: The projected share of vitamin and dietary supplements within the application category in 2026. Demand for fish oil, vitamin D, vitamin E and coenzyme Q10 products supports the segment's market position.

Where Growth Is Strongest

FMI's country-wise comparison identifies several attractive markets for softgel capsule manufacturers and nutraceutical investors.

· South Korea - 6.1% CAGR: Strong demand for functional health foods, omega-3 products, lutein and red ginseng oil softgels supports market development.

· India - 6.0% CAGR: Expanding contract manufacturing capabilities, pharmaceutical exports and rising domestic supplement consumption support market growth.

· United States - 6.0% CAGR: Outsourced supplement production and trade measures affecting imported capsules are supporting opportunities for established domestic suppliers.

· Germany - 5.8% CAGR: Established pharmaceutical demand for liquid-filled medicines and regulated manufacturing requirements support steady growth.

· China - 5.7% CAGR: Increasing online sales of fish oil, vitamin E and herbal oil softgels contribute to demand, although local price competition remains a constraint.

· United Kingdom - 5.5% CAGR: Growing interest in vegetarian and vegan supplements is encouraging manufacturers to introduce plant-based capsule shells.

· Japan - 5.4% CAGR: An established supplement market and increasing interest in premium formulations support gradual market expansion.

These country growth figures reflect FMI's 2026-2036 forecast.

Who Is Moving: Competitive Developments and Key Players

The competitive environment is shaped by gelatin supply expansion, plant-based formulation development, contract manufacturing investments and strategic ownership changes. Manufacturers are focusing on improving production efficiency, expanding formulation capabilities and developing alternatives for consumers seeking vegetarian supplement products.

Several developments highlighted in the report illustrate this activity:

· March 2026: Lonza agreed to divest its Capsules & Health Ingredients business to Lone Star Funds at an enterprise value of CHF 2.3 billion, highlighting investor interest in capsule manufacturing and dosage-form businesses.

· April 2026: Roquette presented LYCAGEL Flex and VERDIGEL SC softgel premixes for plant-based formulations ahead of Vitafoods Europe 2026, expanding options for vegetarian softgel production.

· July 2026: Darling Ingredients reported second-quarter 2026 Food segment sales of USD 408.5 million, compared with USD 386.1 million a year earlier, citing growing global collagen demand.

· July 2026: Lonza reported first-half 2026 Capsules & Health Ingredients sales of CHF 541 million, representing 6.3% growth at constant exchange rates.

· August 2026: GELITA increased its shareholding in SelJel to near-full ownership, strengthening its position in the gelatin supply chain.

· September 2026: Roquette reported first-half 2026 turnover of EUR 2,586 million, while noting continued competitive and pricing pressure in its starch and capsules businesses.

The companies profiled in the FMI report include:

Global Contract Development Groups

· Catalent

· Thermo Fisher Scientific (Patheon)

· Aenova Group

· Procaps Group (Softigel)

· Delpharm Evreux

Supplement-Focused Encapsulators

· Sirio Pharma

· Captek Softgel International

· Soft Gel Technologies

· Curtis Health Caps

· EuroCaps

Regional Producers

· Fuji Capsule

· Guangdong Yichao Biotechnology

· Hunan Er-Kang Pharmaceutical

· United Labs

· Elnova Pharma

· Softgel Healthcare

· Medgel

Where to Act and Where to Be Careful

For pharmaceutical and nutraceutical manufacturers, gelatin softgel production remains an important strategic opportunity. With gelatin formulations accounting for 73.1% of product sales in 2026, established manufacturing capabilities and reliable shell-material sourcing remain essential competitive advantages.

Plant-based softgel development represents another growth opportunity. Increasing interest in vegetarian, vegan and alternative dietary products is encouraging manufacturers to explore pea starch-based and pectin-starch formulations. Companies investing in plant-based premixes can potentially expand their customer base without requiring entirely new production infrastructure.

Vitamin and dietary supplements also offer considerable opportunities. The segment accounts for 31.4% of application demand, supported by consumption of fish oil, vitamin D, vitamin E and other oil-soluble nutritional ingredients.

Contract manufacturing is another important area for investment. Pharmaceutical and supplement brands can use outsourced encapsulation capabilities to expand product portfolios without establishing additional manufacturing facilities.

However, companies should carefully assess gelatin price fluctuations, raw material concentration, manufacturing costs and competitive pricing pressure. Dependence on animal-derived gelatin can also limit market access among consumers seeking vegetarian alternatives. Manufacturers should balance established gelatin production with investments in alternative shell materials and specialized formulations.

Access Full Report: https://www.futuremarketinsights.com/reports/softgel-capsules-market

Analyst Perspective

Anurag Sharma, Principal Consultant at Future Market Insights, observes:

"Softgels are a steady business built on formulation skill, and growth now comes from better fills and new shells more than from price. Plant-based shells will win share in supplements, though gelatin keeps the lead in pharma, as regulators and formulators trust a long history of stability data."

FMI's analysis indicates that supplement consumption, liquid-fill pharmaceutical formulations, plant-based shell innovation and expanding contract manufacturing capabilities will remain important influences on the softgel capsules industry's development through 2036.

Questions for Your Next Planning Meeting

How can manufacturers strengthen gelatin and vegetarian softgel portfolios to address changing pharmaceutical and nutraceutical requirements?
Which geographical markets offer the strongest investment opportunities, particularly South Korea, India and the United States?
How can contract manufacturers improve production efficiency and develop plant-based shell technologies while managing gelatin supply costs?

Explore the Full Softgel Capsules Market Research

Businesses evaluating market entry, product development or investment opportunities can access FMI's research for detailed market forecasts, competitive intelligence, segment analysis and regional assessments.

Related FMI Reports:

· Hard Gelatin Capsules Market - https://www.futuremarketinsights.com/reports/hard-gelatin-capsules-market

· Vision Care Market - https://www.futuremarketinsights.com/reports/vision-care-products-market

· Autoimmune Disease Therapeutics Market - https://www.futuremarketinsights.com/reports/autoimmune-disease-therapeutics-market

Future Market Insights
Email: [email protected]
Phone: +1 347 918 3531
Website: https://www.futuremarketinsights.com/